|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Vital Signs, Inc. (Nasdaq:VITL), a manufacturer of products for anesthesia, respiratory and related critical care applications. |
|---|---|
| Transferring Party | Enginivity LLC, developer of the enFlow® fluid and blood warmer patented technology. |
| Sector | Medical Devices |
| Date | August 15, 2007 |
| Analysis Expands Vital Signs' patient temperature management line and opens up a $40-45 million domestic market, addressable by its anesthesia-related sales force. Maintaining normal body temperature during surgery is an important factor in reducing post-operative infections. Deal value - $5.9m | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |